Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v13-EN | Version v2-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2023-01-27 | 2022-12-22 |
| Drug Identification Number | 02248641 | 02248641 |
| Brand name | OCTREOTIDE ACETATE OMEGA | OCTREOTIDE ACETATE OMEGA |
| Common or Proper name | Octreotide Acetate Injection | Octreotide Acetate Injection |
| Company Name | OMEGA LABORATORIES LIMITED | OMEGA LABORATORIES LIMITED |
| Ingredients | OCTREOTIDE | OCTREOTIDE |
| Strength(s) | 500MCG | 500MCG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS | SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS |
| Packaging size | 5 x 1mL vial / fiole | 5 x 1mL vial / fiole |
| ATC code | H01CB | H01CB |
| ATC description | HYPOTHALAMIC HORMONES | HYPOTHALAMIC HORMONES |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | 2023-01-05 | |
| Actual start date | 2023-01-05 | |
| Estimated end date | 2023-01-31 | 2023-01-13 |
| Actual end date | 2023-01-26 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |